PubMed:32559589 / 0-189 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":36,"end":47},"obj":"CHEBI:3638"},{"id":"T2","span":{"begin":36,"end":47},"obj":"DG_10"},{"id":"T3","span":{"begin":36,"end":47},"obj":"CHEBI:3638"},{"id":"T4","span":{"begin":51,"end":69},"obj":"CHEBI:5801"},{"id":"T5","span":{"begin":51,"end":69},"obj":"DG_20"},{"id":"T6","span":{"begin":51,"end":69},"obj":"CHEBI:5801"},{"id":"T7","span":{"begin":82,"end":90},"obj":"SP_7"},{"id":"T8","span":{"begin":94,"end":101},"obj":"NCBITaxon:1"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":82,"end":90},"obj":"Disease"},{"id":"T2","span":{"begin":107,"end":115},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005027"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":36,"end":47},"obj":"Chemical"},{"id":"T2","span":{"begin":51,"end":69},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":116},"obj":"Sentence"},{"id":"T2","span":{"begin":117,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":22,"end":30},"obj":"Phenotype"},{"id":"T2","span":{"begin":107,"end":115},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}

{"project":"hydroxychloroquine","denotations":[{"id":"T1","span":{"begin":22,"end":30},"obj":"Phenotype"},{"id":"T2","span":{"begin":107,"end":115},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.\nBACKGROUND: The goal of this systematic review is to assess the publishe"}